ArticleJournal of epidemiology and global health2025
The Precarious Future of HIV and AIDS Programs in Zimbabwe Following International Funding Freeze: Impact and Strategic Interventions.
Article in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The burden and risk factors of NCDs in Zimbabwe: evidence from the Zimbabwe population based HIV impact assessment 2020 survey.BMC public health · 2026Article
- Early impacts of PEPFAR funding freeze on HIV service delivery in mid-Western Uganda.BMC health services research · 2026Article
- Article
- The impact of US Government Stop Work Order on HIV epidemic trajectory in Zimbabwe.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past few decades, significant progress has been made in the global fight against HIV and AIDS, largely driven by international funding mechanisms such as the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund. These initiatives have been instrumental in expanding access to antiretroviral therapy (ART), implementing prevention programs, and strengthening healthcare infrastructure, particularly in Sub-Saharan Africa (SSA), a region disproportionately affected by HIV. Zimbabwe, in particular, has achieved remarkable success in combating the epidemic, recently meeting the UNAIDS 95-95-95 fast-track targets, a testament to sustained international support and national commitment. However, the recent suspension of foreign aid, including funding for HIV programs, threatens to undermine these gains. For Zimbabwe, a prolonged freeze could lead to a resurgence of new infections, an increase in AIDS-related mortality, and further strain on Zimbabwe's already fragile healthcare system. This commentary examines the potential consequences of the aid suspension on Zimbabwe's HIV and AIDS response and explores strategies to mitigate its impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.